Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Practice & Research Clinical Endocrinology & Metabolism 2013; 27: 647–661. https://doi.org/10.1016/j.beem.2013.05.011

Başok Banu Işbilen. Understanding and managing biotin interference in immunoassays. Int J Med Biochem. 2020. https://doi.org/10.14744/ijmb.2020.48303

Kabiri P, Weiskirchen R, van Helden J. The biotin interference within interference suppressed immunoassays. J Clin Lab Anal 2021; 35: e23940. https://doi.org/10.1002/ jcla.23940

Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Front Endocrinol (Lausanne). 2020; 11: 1.

Men CJ, Kossler AL, Wester ST. Updates on the understanding and management of thyroid eye disease. Ther Adv Ophthalmol 2021; 13: 1–14. Kortokorezistentna Grejvsova orbitopatija – terapijske opcije 83

Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ dis